ArticleAntimicrobial agents and chemotherapy2020

KPC-53, a KPC-3 Variant of Clinical Origin Associated with Reduced Susceptibility to Ceftazidime-Avibactam.

Vincenzo Di Pilato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.